Later, Ifon et al. [27] demonstrated the anticancer activity of U94 on human prostate cancer in vivo, as the development of human prostate cancer (PC3) cell line-derived tumor in nude mice was inhibited by treatment with a recombinant U94 protein. The gene discussed is SNORD94; the disease is prostate carcinoma.